SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-15-221898
Filing Date
2015-06-12
Accepted
2015-06-12 16:39:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 ON FORM S-3 d936527dposam.htm POS AM 391920
2 EX-23.1 d936527dex231.htm EX-23.1 1777
  Complete submission text file 0001193125-15-221898.txt   394885
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-203077 | Film No.: 15928934
SIC: 2834 Pharmaceutical Preparations